IMRT-Physics Aspects

S. Jack Wei, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 22 de octubre del 2003

Share article


Moderator: Theodore L. Phillips, MD., University of California, San Francisco

Lynn J. Verhey, PhD., University of California, San Francisco

  • IMRT is now commonly used for patient treatment.
  • Compared to 3D conformal treatment (3DCRT), IMRT requires increased commissioning time, increased treatment time, increased physics and dosimetry time, and patient-specific quality assurance (QA).
  • Due to the increased number of fields and small monitor units used per field, specific commissioning is required.
  • Specific commissioning and QA is needed for the multi-leaf collimators to verify leaf position, minimize leakage, etc.
  • The varying linear accelerators each have their own requirements (e.g. leaf design, interleaf field constraints, field size, etc.) depending on their manufacturer, and these each must be commissioned and verified.
  • Patient immobilization and target definition must be carefully performed.
  • Improved imaging during treatment is important for improving QA and the emerging technology of cone-beam CT has the potential to determine patient translation and rotation relative to a pre-treatment CT scan.
  • In conclusion, IMRT is increasingly becoming mature and requires vigilant and extensive QA
  • Improved imaging will allow better delivery of QA.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información